Abstract
The metastatic colorectal cancer (mCRC) prognostic score (mCCS) predicts overall survival (OS) of patients (pts) with mCRC at start of 1st-line therapy (Marschner N, et al. Colorectal Dis. 2019). Based on 5 clinical routine parameters, i.e. tumor stage, tumor grading and lymph node (LN) ratio (affected LNs / total number of resected LNs) at primary diagnosis, primary tumor resectability and number of metastatic sites at start of 1st-line treatment, pts were assigned to three prognostic risk groups with decreasing OS from low to intermediate and high risk group.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
